Franklin Resources’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-255,661
| Closed | -$33.7M | – | 3164 |
|
|
2025
Q1 | $33.7M | Sell |
255,661
-1,521,219
| -86% | -$190M | 0.01% | 730 |
|
|
2024
Q4 | $148M | Buy |
1,776,880
+23,594
| +1% | +$1.94M | 0.04% | 362 |
|
|
2024
Q3 | $129M | Buy |
1,753,286
+155,655
| +10% | +$11.7M | 0.04% | 385 |
|
|
2024
Q2 | $109M | Sell |
1,597,631
-21,932
| -1% | -$1.52M | 0.03% | 392 |
|
|
2024
Q1 | $112M | Sell |
1,619,563
-160,597
| -9% | -$11M | 0.04% | 391 |
|
|
2023
Q4 | $127M | Sell |
1,780,160
-7,904
| -0.4% | -$455K | 0.06% | 313 |
|
|
2023
Q3 | $93.1M | Sell |
1,788,064
-20,165
| -1% | -$1.17M | 0.05% | 364 |
|
|
2023
Q2 | $114M | Buy |
1,808,229
+16,040
| +0.9% | +$1,000K | 0.05% | 343 |
|
|
2023
Q1 | $97M | Sell |
1,792,189
-1,267
| -0.1% | -$61.3K | 0.05% | 371 |
|
|
2022
Q4 | $94.9M | Sell |
1,793,456
-3,954
| -0.2% | -$198K | 0.05% | 382 |
|
|
2022
Q3 | $83.6M | Buy |
1,797,410
+97,680
| +6% | +$5.1M | 0.05% | 409 |
|
|
2022
Q2 | $97M | Buy |
1,699,730
+1,034
| +0.1% | +$58.6K | 0.05% | 381 |
|
|
2022
Q1 | $104M | Buy |
1,698,696
+612,014
| +56% | +$31.8M | 0.04% | 425 |
|
|
2021
Q4 | $56.9M | Sell |
1,086,682
-277,977
| -20% | -$11.7M | 0.02% | 602 |
|
|
2021
Q3 | $50.9M | Buy |
1,364,659
+7
| +0% | +$243 | 0.02% | 653 |
|
|
2021
Q2 | $55.7M | Buy |
1,364,652
+196,106
| +17% | +$7.25M | 0.02% | 613 |
|
|
2021
Q1 | $39.6M | Buy |
+1,168,546
| New | +$40.5M | 0.02% | 683 |
|
|
2019
Q3 | – | Sell |
-614,700
| Closed | -$7.98M | – | 1571 |
|
|
2019
Q2 | $7.98M | Hold |
614,700
| – | – | ﹤0.01% | 942 |
|
|
2019
Q1 | $7.49M | Hold |
614,700
| – | – | ﹤0.01% | 940 |
|
|
2018
Q4 | $7M | Buy |
614,700
+121,600
| +25% | +$1.96M | ﹤0.01% | 937 |
|
|
2018
Q3 | $10.7M | Buy |
+493,100
| New | +$10.3M | 0.01% | 918 |
|
|
2016
Q3 | – | Sell |
-253,000
| Closed | -$9.82M | – | 1527 |
|
|
2016
Q2 | $9.82M | Hold |
253,000
| – | – | 0.01% | 971 |
|
|
2016
Q1 | $7.03M | Sell |
253,000
-198,900
| -44% | -$6.63M | ﹤0.01% | 1043 |
|
|
2015
Q4 | $24.3M | Sell |
451,900
-15,600
| -3% | -$787K | 0.01% | 775 |
|
|
2015
Q3 | $18.7M | Buy |
467,500
+100,800
| +27% | +$3.29M | 0.01% | 866 |
|
|
2015
Q2 | $11.7M | Hold |
366,700
| – | – | 0.01% | 1006 |
|
|
2015
Q1 | $8.76M | Sell |
366,700
-132,200
| -26% | -$2.96M | ﹤0.01% | 1077 |
|
|
2014
Q4 | $8.81M | Sell |
498,900
-60,900
| -11% | -$952K | ﹤0.01% | 1073 |
|
|
2014
Q3 | $7.67M | Sell |
559,800
-268,300
| -32% | -$4.03M | ﹤0.01% | 1092 |
|
|
2014
Q2 | $14M | Sell |
828,100
-12,200
| -1% | -$202K | 0.01% | 975 |
|
|
2014
Q1 | $15.3M | Buy |
+840,300
| New | +$15.2M | 0.01% | 922 |
|
Other funds holding ITCI
KIM
HNB
Franklin Resources's ITCI Position: Q2 2025 in Review
Franklin Resources sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 255,661 shares — an estimated $33.7M sold.
Franklin Resources first reported a position in ITCI in Q1 2014 and held it in 31 quarters. The position peaked at $148M in Q4 2024. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.
- Franklin Resources reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
- Franklin Resources sold 255,661 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $33.7M.
- Franklin Resources first reported a position in Intra-Cellular Therapies Inc. in Q1 2014 and held it in 31 quarters.
- Franklin Resources's Intra-Cellular Therapies Inc. position peaked at $148M in Q4 2024.
- 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.
Based on Franklin Resources's 13F filing for Q2 2025, filed 12 Aug 2025.